Stockscreener 앱 받기
10.08
0.00%
0.00
Drugs Made In America Acquisition Ii Corp 주식(DMII)의 최신 뉴스
Free float of Drugs Made In America Acquisition Corp. – NASDAQ:DMAAR - TradingView
QDRO Acquisition Corp.: Performance & Quotes, QADR Stock Price on Nasdaq Exchange - marketscreener.com
Drugs Made In America Acquisition II Corp. appoints new CEO after sponsor repayment issue - Investing.com
Shalibhadra Finance Targets Rs 500 Crore AUM on 22% Profit Growth in FY26Net Income Trends - The Legal Advocate
Drugs Made In America Acquisition II Corp. Right (DMIIR) Drops 10% as Rights Trade Near Support at $0.08Volatility Breakout Picks - The Legal Advocate
Drugs Made In America Acquisition II Corp. Unit (DMIIU) Holds Steady Amid Extended ConsolidationVolatility Smirk - The Legal Advocate
NXRT Q1 2026 Earnings: Narrower-Than-Expected Loss, Stock Edges LowerBanking Earnings Report - thelegaladvocate.com
Drugs Made In America Acquisition II Corp. Right (DMIIR) Moves Up 8.91% at $0.09 – Right Securities See Renewed InterestGamma Squeeze - The Legal Advocate
NXGL Q1 2026 Earnings: Larger-Than-Expected Loss Weighs on SharesEarnings Manipulation Risk - thelegaladvocate.com
Trump Media & Technology Group (DJT) Rises 3.5% as Stock Bounces From SupportBackspread Trade - thelegaladvocate.com
Eli Lilly and Company - Britannica
DMIIU Units Edge Lower by 0.44% as Price Holds Near $10.11 Amid Quiet TradingVWAP Breakout - The Legal Advocate
Drugs Made In America Acquisition II Corp. Unit (DMIIU) Holds Steady Near Trust Value Amid Low VolatilityInstitutional Sentiment - The Legal Advocate
Huadi International Group (HUDI) Faces Steep Decline, Testing Key Support at $1.0Turnaround Stocks - thelegaladvocate.com
SAGU_u|SAGU_u.NB|Price:10.090|Chg%:0.04 - TradingKey
symbol__ Stock Quote Price and Forecast - CNN
MMCAP International Inc. SPC's Drugs Made In America Acquisition II Corp(DMII) Holding History - GuruFocus
Layoff Tracker: AbbVie, Novartis slash US headcount - BioSpace
Trump-Xi Summit: The 3 Big Takeaways from Historic Meeting in BeijingReturn On Equity - The Legal Advocate
DMAA SEC FilingsDrugs Made In Amer Acqutn Corp 10-K, 10-Q, 8-K Forms - Stock Titan
Trump and Mark Cuban team up to take on America's drug pricing crisis - Fortune
Baxfendy approved in the US as the first and only aldosterone synthase inhibitor treatment for adults with hypertension - AstraZeneca
HEIGHTS CAPITAL MANAGEMENT, INC's Drugs Made In America Acquisition II Corp(DMIIU) Holding History - GuruFocus
Shutterstock, Inc. 8-K Filing: UK CMA Approves Merger with Getty Images Holdings, Inc - Minichart
Number of shareholders of Drugs Made In America Acquisition II Corp. – NASDAQ:DMII - TradingView
GUACU|Berto Acquisition II Units (Proposed)|Price:10.100|Chg%:0.06 - TradingKey
DMAA Price Today: Drugs Made In America Acquisition Corp. Stock Price, Quote & Chart | MEXC - MEXC
Drugs Made In America Acquisition Corp. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
[10-Q] Drugs Made In America Acquisition Corp. Quarterly Earnings Report - Stock Titan
Drugs Made In America Acquisition II Corp. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Drugs Made in America II (DMII) Q1 profit from trust interest amid going-concern risk - Stock Titan
Mizuho Financial Group reports 2,000,000 DMAA shares (DMAA) on 05/14/2026 - Stock Titan
Number of shareholders of Drugs Made In America Acquisition Corp. – NASDAQ:DMAA - TradingView
BWIV|Blue Water Acquisition IV Redeemable Units|Price:9.925|Chg%:0.01 - TradingKey
'Drugs Made In America' SPAC Eyes $1B Deal With AI Platform - Law360
QRED|QuasarEdge Acquisition Units|Price:9.920|Chg%:-0.03 - TradingKey
Drugs Made In America Acquisition Corp (DMAA) and Power Analytics Global Corp Announce Definitive $1B AI Merger Agreement - Minichart
Vector Science and Therapeutics Corp.: Performance & Quotes, PAIN Stock Price on Toronto S.E. Exchange - marketscreener.com
Drugs Made In America Acquisition Announces PAGC Merger Deal - TipRanks
Drugs Made In America Acquisition to Merge With Power Analytics Global in Deal Valued Up to $1 Billion - TradingView
DMAA (NASDAQ: DMAA) to combine with Power Analytics Global; $1.0B target valuation - Stock Titan
DMAA (NASDAQ: DMAA) sets $1.0B PAGC merger with 90/10 ownership split - Stock Titan
Leadership Compensation Aligned With Future Business Combination - TipRanks
Shareholders Approve Extension of SPAC Business Combination Deadline - The Globe and Mail
DMAA Corp Extends Business Combination Deadline to April 29, 2027 Following Shareholder Approval – SEC 8-K Filing Update - Minichart
Drugs Made in America (NASDAQ: DMAA) holders redeem $99M from SPAC trust - Stock Titan
QLEP_u|Quantum Leap Acquisition Units (Proposed)|Price:10.010| - TradingKey
Talon Resources plc: Shareholders Board Members Managers and Company Profile | GB00BM8SQP62 - marketscreener.com
Talon Resources plc Stock (TAR)Quote London S.E. - marketscreener.com
Drugs Made In America Acquisition Updates Executive Compensation Agreements - The Globe and Mail
WENC_u|West Enclave Merger Units (Proposed)|Price:10.090|Chg%:0.09 - TradingKey
Beng Kuang Marine Receives SGX Approval for Listing of 57 Million New Shares for Asian Sealand Acquisition - Minichart
Drugs Made In America Acquisition II Corp. Updates CFO and CEO Compensation Agreements and Share Grant Terms - Minichart
[8-K] Drugs Made In America Acquisition II Corp. Reports Material Event - Stock Titan
Drugs Made in America (NASDAQ: DMAA) details new CEO pay deal - Stock Titan
0.15%
0.10%
자본화:
|
볼륨(24시간):